Good week: Calum Paterson

HE MAY not have put an exact figure on the size of the windfall, but Scottish Equity Partners' (SEP) managing director was celebrating this week after life science firm BioVex was sold for $1 billion (£630 million) to US firm Amgen.

SEP was "one of BioVex's largest investors", having pumped in about 9m, and Paterson said: "We will make an excellent return."